Get notified when SDEV files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Pre-funded Warrants Issued January 16, 2026, Will Be Convertible, In the Aggregate, Into Approximately 87% of the Total Number of Shares of Common Stock Outstanding On a Fully Diluted Basis. (new) — Massive potential dilution from pre-funded warrants could significantly reduce the value of new investors' shares.
NovaBay Pharmaceuticals launches up to $100M at-the-market offering, netting $97.8M to buy digital assets like SKY
Filed January 20, 2026 · ~1 min read
Key Changes
-
high
Company may sell up to $100M of common stock in an at-the-market offering, with net proceeds of approximately $97.8M.
The Offering verify on EDGAR → -
high
Net proceeds are earmarked for general corporate purposes, primarily to acquire and hold revenue-generating digital assets, with SKY as the first approved asset.
Use of Proceeds verify on EDGAR → -
high
New investors pay $14.77 per share but receive only $7.78 in net tangible book value, an immediate dilution of $6.99 per share.
Dilution verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NTSK 10-Q) is open in full — no account needed.
Partner
Trade SDEV commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify